FCNTX
Price
$26.88
Change
+$0.09 (+0.34%)
Updated
Jul 10 closing price
Net Assets
179.96B
VIGAX
Price
$269.93
Change
+$1.25 (+0.47%)
Updated
Jul 10 closing price
Net Assets
379.21B
Interact to see
Advertisement

FCNTX vs VIGAX

FCNTX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
FCNTX vs. VIGAX commentary
Jul 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCNTX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 379B vs. FCNTX (180B). VIGAX pays higher dividends than FCNTX: VIGAX (0.38) vs FCNTX (0.00). FCNTX was incepted earlier than VIGAX: FCNTX (59 years) vs VIGAX (26 years). FCNTX (0.74) is less costly to investors than VIGAX (0.05). FCNTX is a more actively managed with annual turnover of: 29.00 vs. VIGAX (12.00). FCNTX has a lower initial minimum investment than VIGAX: FCNTX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 18.55 vs. FCNTX (15.02). VIGAX return over 5 years is better than : 78.94 vs. FCNTX (42.11).
FCNTXVIGAXFCNTX / VIGAX
Total Expense Ratio0.740.051,480%
Annual Report Gross Expense Ratio0.740.051,480%
Fund Existence59 years26 years-
Gain YTD10.6177.482142%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets180B379B47%
Annual Yield % from dividends0.000.38-
Returns for 1 year15.0218.5581%
Returns for 3 years81.4286.2694%
Returns for 5 years42.1178.9453%
Returns for 10 years172.20375.6746%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCYSX16.750.23
+1.39%
NYLI Candriam Emerging Markets Eq Cl R6
VLACX140.430.55
+0.39%
Vanguard Large Cap Index Investor
MMNBX9.520.03
+0.32%
MassMutual Diversified Value Y
BDBKX32.32-0.15
-0.46%
iShares Russell 2000 Small-Cap Idx K
GTMUX25.99-0.26
-0.99%
Goldman Sachs Small/Mid Cap Growth R6